Related Experiment Video
Updated: Aug 6, 2025
07:50
Genome-Wide Analysis of DNA Methylation in Gastrointestinal Cancer
Published on: September 18, 2020
5.6K
Pregnancy-associated gastric cancer
Ewelina Stefanowicz1, Piotr Minowski2, Maja Bronk2
1Department of Gynecology and Obstetrics, Kociewie Health Center, Starogard Gdanski, Poland, Poland. ewelina.stefanowicz@gmail.com.
Ginekologia Polska
|March 17, 2023
Summary
Gastric cancer during pregnancy is rare but serious. Early detection and prompt intervention are crucial for improving survival rates for both mother and fetus.
Area of Science:
- Oncology
- Obstetrics & Gynecology
Background:
- Gastric cancer is exceptionally rare in pregnancy, affecting approximately 1 in 1000 pregnancies.
- This diagnosis poses significant risks to maternal and fetal health, complicating diagnostic and therapeutic pathways.
Purpose of the Study:
- To highlight the challenges and importance of early diagnosis in pregnancy-associated gastric cancer.
- To present a case study illustrating the diagnostic and management approach.
Main Methods:
- The study describes a case of gastric cancer diagnosed in the third trimester of pregnancy.
- Diagnosis was confirmed via histopathological examination of samples obtained during a laparotomy with cesarean section.
Main Results:
- The patient underwent a laparotomy with cesarean section due to suspected gastrointestinal perforation.
- Histopathological analysis confirmed gastric cancer, leading to a diagnosis of pregnancy-associated gastric cancer.
Conclusions:
- Oncological vigilance and prompt decision-making are vital for enhancing survival in pregnancy-associated gastric cancer.
- Underestimating symptoms can impede timely diagnosis and treatment, underscoring the need for heightened awareness.
Related Concept Videos
01:30Peptic Ulcer Disease I: Introduction
237
Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
237
01:27Gastritis-I: Introduction and Types
641
Gastritis, defined by the inflammation or irritation of the stomach lining or gastric mucosa, manifests in several distinct forms: acute, chronic, reactive, and a specific subtype known as autoimmune metaplastic atrophic gastritis.
Acute gastritis presents as a sudden inflammation triggered by various stressors to the stomach lining, such as exposure to corrosive agents, local irritants like aspirin and other NSAIDs, alcohol consumption, radiation therapy, physical trauma, severe burns, sepsis,...
Acute gastritis presents as a sudden inflammation triggered by various stressors to the stomach lining, such as exposure to corrosive agents, local irritants like aspirin and other NSAIDs, alcohol consumption, radiation therapy, physical trauma, severe burns, sepsis,...
641
01:17Gastritis-II: Pathophysiology
418
Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
418
01:23Gastritis III: Clinical Manifestations and Management
357
The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
357
01:20Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
544
The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
544
01:28Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
168
Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
168